Mesenchymal stem/stromal cells (MSCs) represent a heterogenous population of cells residing in a quiescent, undifferentiated state across various connective tissues. Their reliable identification is essential for both research and applications in regenerative medicine. As no single specific marker exists, their identification requires the analysis of a combination of positive and negative cellular markers. Multicolour flow cytometry enables precise immunophenotyping of MSCs, however, it requires careful panel design and optimization.
The aim of this master's thesis was to optimize a multicolour flow cytometry panel for immunophenotyping of primary human MSCs, with a focus on cells derived from perinatal tissues. Based on the guidelines of the International Society for Cell and Gene Therapy (ISCT) and a review of the literature, we selected appropriate negative (CD45, CD235a, CD146) and positive markers (CD73, CD105, CD90), as well as additional markers PDPN and CD164 to define a novel population of human skeletal stem cells (hSSCs). We optimized the panel through the stepwise inclusion of antibodies, determination of optimal reagent volumes, and adjustment of flow cytometer settings. The performance of the optimized panel was evaluated using fluorescence minus one (FMO) controls, which also aided in establishing accurate gating between positive and negative populations.
The optimization results were continuously analyzed to identify opportunities for improvement. Analysis of FMO controls provided deeper insight into background fluorescence, as well as potential spectral overlap and spreading. The applicability of the optimized panel was further tested on primary cell samples derived from the placenta, where immunophenotyping was used to determine the proportions of the investigated cell populations. The results demonstrated high expression of CD73 and variable expression of CD105 and CD90, reflecting the heterogeneity of MSC populations, while PDPN expression indicated the presence of MSC subpopulations.
The optimized panel represents a useful method for MSC immunophenotyping, incorporating both established and emerging markers, and provides a solid foundation for further research in the field of stem cells. At the same time, it offers flexibility for future improvements and the integration of potential new markers.
|